Drugs / Cyclo-Progynova
last change Jan 2023 re-read 3 minutes ago

Cyclo-Progynova

Developed for
ovarian neoplasm

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy2 trials
Phase 3 NCT05244811 Comparator Feb 2022 → Jan 2023 ovarian neoplasm Sohag University Unknown No outcome recorded
Phase 3 NCT04537078 Comparator Sep 2020 → Mar 2021 female infertility El Shatby University Hospital for Obstetrics and Gynecology Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Cyclo-Progynova “cyclo progynova” NCT05244811 ↗
1

NCT04537078 ↗